US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted A61KA61K31/337A61K31/4706
Quick answer
US patent 12428455 (Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells) held by The Regents of the University of California expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/337, A61K31/4706, A61K31/704, A61K38/00